Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Broadening indications for neoadjuvant immunotherapy.
Blankenstein SA, van Akkooi ACJ. Blankenstein SA, et al. Among authors: van akkooi acj. Br J Dermatol. 2020 Sep;183(3):421-422. doi: 10.1111/bjd.18873. Epub 2020 Feb 3. Br J Dermatol. 2020. PMID: 32017031 No abstract available.
Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma.
Schermers B, Franke V, Rozeman EA, van de Wiel BA, Bruining A, Wouters MW, van Houdt WJ, Ten Haken B, Muller SH, Bierman C, Ruers TJM, Blank CU, van Akkooi ACJ. Schermers B, et al. Among authors: van de wiel ba, van akkooi acj, van houdt wj. Br J Surg. 2019 Apr;106(5):519-522. doi: 10.1002/bjs.11168. Epub 2019 Mar 18. Br J Surg. 2019. PMID: 30882901 Free PMC article. Clinical Trial.
Adjuvant systemic therapy in high-risk melanoma.
Blankenstein SA, van Akkooi ACJ. Blankenstein SA, et al. Among authors: van akkooi acj. Melanoma Res. 2019 Aug;29(4):358-364. doi: 10.1097/CMR.0000000000000604. Melanoma Res. 2019. PMID: 30896556 Review.
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA; International Neoadjuvant Melanoma Consortium members; Ascierto PA, Spillane AJ, van Akkooi ACJ, Wargo JA, Blank CU, Tawbi HA, Long GV. Amaria RN, et al. Among authors: van de wiel ba, van akkooi acj. Lancet Oncol. 2019 Jul;20(7):e378-e389. doi: 10.1016/S1470-2045(19)30332-8. Lancet Oncol. 2019. PMID: 31267972 Review.
Surgery for Metastatic Melanoma: an Evolving Concept.
Testori AAE, Blankenstein SA, van Akkooi ACJ. Testori AAE, et al. Among authors: van akkooi acj. Curr Oncol Rep. 2019 Nov 6;21(11):98. doi: 10.1007/s11912-019-0847-6. Curr Oncol Rep. 2019. PMID: 31696407 Review.
Primary Melanoma: from History to Actual Debates.
Testori AAE, Blankenstein SA, van Akkooi ACJ. Testori AAE, et al. Among authors: van akkooi acj. Curr Oncol Rep. 2019 Dec 19;21(12):112. doi: 10.1007/s11912-019-0843-x. Curr Oncol Rep. 2019. PMID: 31858280 Review.
250 results